Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Xenotransplantation industry 360° synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Application trends
2.6 End-use trends
Chapter 3 Xenotransplantation Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for tissue and organ transplantation
3.2.1.2 Advancements in genetic engineering
3.2.1.3 Growing number of surgical procedures
3.2.1.4 High investment in research and development activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory scenario
3.2.2.2 Dearth of skilled professionals
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Xenotransplantation Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Organ preservation solution
5.3 Transplant diagnostics
5.4 Xeno products
5.4.1 Organ
5.4.2 Cell
5.4.3 Tissue
5.5 Others
Chapter 6 Xenotransplantation Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Kidney
6.3 Heart
6.4 Liver
6.5 Lung
6.6 Others
Chapter 7 Xenotransplantation Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Transplant centers
7.3 Hospitals
7.4 Others
Chapter 8 Xenotransplantation Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Switzerland
8.3.7 The Netherlands
8.3.8 Denmark
8.3.9 Poland
8.3.10 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 New Zealand
8.4.7 Vietnam
8.4.8 Indonesia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Turkey
Chapter 9 Company Profiles
9.1 Novartis AG
9.2 United Therapeutics Corporation
9.3 Immerge BioTherapeutics, Inc
9.4 eGenesis, Inc.
9.5 Infigen, Inc.
9.6 NZeno Limited
9.7 Xeno Transplants Corporation
9.8 Preservation Solutions, Inc.
9.9 F. Hoffmann-La Roche Ltd.
9.10 OrganOX Limited
